Novelix Pharmaceuticals Limited has provided prior intimation of a Board of Directors meeting scheduled for Thursday, 04th June, 2026, to be held at the company's registered office in Hyderabad. The intimation is made pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Board meeting agenda includes:
- Consideration and potential approval of issuance of securities on a preferential basis in accordance with the Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, subject to regulatory/statutory approvals and shareholder approval
- Adoption and approval of the Draft Notice of Extra Ordinary General Meeting
- Fixing the day, date, time, and venue of the Extra Ordinary General Meeting
- Appointment of Scrutinizer for conducting the E-voting process for the Extra Ordinary General Meeting
- Any other matter with the permission of the chair
In accordance with the company's Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the company's securities has been closed for all Designated Persons and their relatives effective from 01st June, 2026. The Trading Window will remain closed until 48 hours after the announcement is made available to the public.